Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prodocs Solutions Limited's Board of Directors, on recommendation of the Nomination and Remuneration Committee, has approved the formulation of an Employee Stock Option Scheme 2026 (ESOP Scheme 2026). The scheme authorises the grant of stock options aggregating 3,50,000 (3.5 lakh) equity shares of ₹10 each, representing 4.96% of the company's paid-up share capital as of March 31, 2026. The exercise price will be determined by the Compensation Committee, ranging from face value to the previous day's closing market price. The scheme is compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Implementation is subject to approval by shareholders via a Special Resolution and any other applicable regulatory approvals.
Approval of a new ESOP scheme is a positive signal for talent retention and alignment of employee interests with shareholders, though it will result in dilution of approximately 4.96% of equity. Final shareholder approval is still pending.